Albertine Léon
Research Subjects
Research Interests
Albertine Léon has a total of 139 co-authors. Here are the top co-authors by number of shared publications:
- Florence Tardy
Université de Lyon, Anses, VetAgro Sup, UMR mycoplasmoses animales, 69007, Lyon, France
3 shared publications - Jean-Christophe Giard
Université de Caen Normandie, Univ Rouen Normandie, INSERM, Normandie Univ, DYNAMICURE UMR 1311
3 shared publications Sophie Castagnet
LABÉO, Research Department, St Contest Caen France
3 shared publications- Andrew Stephen Waller
Intervacc AB Stockholm Sweden
2 shared publications Clément Pillon
LABÉO Frank Duncombe, 1 route de Rosel, 14280 Saint-Contest
2 shared publications- Coralie Lupo
RESPE 3, rue Nelson Mandela 14280 Saint-Contest
2 shared publications
Latest Publications
- Open Access
- 28 March 2025
- Published by Microbiology Society in Microbial Genomics
- Vol. 11 (3) , 001366
Progressive evolution of Streptococcus equi from Streptococcus equi subsp. zooepidemicus and adaption to equine hosts
Streptococcus equi subsp. equi causes the equine respiratory disease ‘strangles’, which is highly contagious, debilitating and costly to the equine industry. S. equi emerged from the ancestral Streptococcus equi subsp. zooepidemicus and continues to evolve and disseminate globally. Previous work has shown that there was a global population replacement around the beginning of the twentieth century, obscuring the early genetic events in this emergence. Here, we have used large-scale genomic analysis of S. equi and its ancestor S. zooepidemicus to identify evolutionary events, leading to the successful expansion of S. equi. One thousand two hundred one whole-genome sequences of S. equi were recovered from clinical samples or from data available in public databases. Seventy-four whole-genome sequences representative of the diversity of S. zooepidemicus were used to compare the gene content and examine the evolutionary emergence of S. equi. A dated Bayesian phylogeny was constructed, and ancestral state reconstruction was used to determine the order and timing of gene gain and loss events between the different species and between different S. equi lineages. Additionally, a newly developed framework was used to investigate the fitness of different S. equi lineages. We identified a novel S. equi lineage, comprising isolates from donkeys in Chinese farms, which diverged nearly 300 years ago, after the emergence of S. equi from S. zooepidemicus, but before the global sweep. Ancestral state reconstruction demonstrated that phage-encoded virulence factors slaA, seeL and seeM were acquired by the global S. equi after the divergence of the basal donkey lineage. We identified the equibactin locus in both S. equi populations, but not S. zooepidemicus, reinforcing its role as a key S. equi virulence mechanism involved in its initial emergence. Evidence of a further population sweep beginning in the early 2000s was detected in the UK. This clade now accounts for more than 80% of identified UK cases since 2016. Several sub-lineages demonstrated increased fitness, within which we identified the acquisition of a new, fifth prophage containing additional toxin genes. We definitively show that acquisition of the equibactin locus was a major determinant in S. equi becoming an equid-exclusive pathogen, but that other virulence factors were fixed by the population sweep at the beginning of the twentieth century. Evidence of a secondary population sweep in the UK and acquisition of further advantageous genes implies that S. equi is continuing to adapt, and therefore, continued investigations are required to determine further risks to the equine industry.
- 28 March 2025
- Published by Microbiology Society in Microbial Genomics
- Vol. 11 (3) , 001366
Open AccessProgressive evolution of Streptococcus equi from Streptococcus equi subsp. zooepidemicus and adaption to equine hosts
Streptococcus equi subsp. equi causes the equine respiratory disease ‘strangles’, which is highly contagious, debilitating and costly to the equine industry. S. equi emerged from the ancestral Streptococcus equi subsp. zooepidemicus and continues to evolve and disseminate globally. Previous work has shown that there was a global population replacement around the beginning of the twentieth century, obscuring the early genetic events in this emergence. Here, we have used large-scale genomic analysis of S. equi and its ancestor S. zooepidemicus to identify evolutionary events, leading to the successful expansion of S. equi. One thousand two hundred one whole-genome sequences of S. equi were recovered from clinical samples or from data available in public databases. Seventy-four whole-genome sequences representative of the diversity of S. zooepidemicus were used to compare the gene content and examine the evolutionary emergence of S. equi. A dated Bayesian phylogeny was constructed, and ancestral state reconstruction was used to determine the order and timing of gene gain and loss events between the different species and between different S. equi lineages. Additionally, a newly developed framework was used to investigate the fitness of different S. equi lineages. We identified a novel S. equi lineage, comprising isolates from donkeys in Chinese farms, which diverged nearly 300 years ago, after the emergence of S. equi from S. zooepidemicus, but before the global sweep. Ancestral state reconstruction demonstrated that phage-encoded virulence factors slaA, seeL and seeM were acquired by the global S. equi after the divergence of the basal donkey lineage. We identified the equibactin locus in both S. equi populations, but not S. zooepidemicus, reinforcing its role as a key S. equi virulence mechanism involved in its initial emergence. Evidence of a further population sweep beginning in the early 2000s was detected in the UK. This clade now accounts for more than 80% of identified UK cases since 2016. Several sub-lineages demonstrated increased fitness, within which we identified the acquisition of a new, fifth prophage containing additional toxin genes. We definitively show that acquisition of the equibactin locus was a major determinant in S. equi becoming an equid-exclusive pathogen, but that other virulence factors were fixed by the population sweep at the beginning of the twentieth century. Evidence of a secondary population sweep in the UK and acquisition of further advantageous genes implies that S. equi is continuing to adapt, and therefore, continued investigations are required to determine further risks to the equine industry.
- 4 February 2025
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
Emergence of MRSA ST612 in horses and of MSSA CC398 in cats in France
Objectives: Staphylococcus aureus is an important zoonotic pathogen that has often been seen in animals through the prism of the MRSA clonal complex (CC) 398 in pigs and in-contact humans. The goal of this study was first to assess the prevalence of MRSA, and second to look for MSSA CC398 in cats, dogs and horses in France. Methods: Clinical S. aureus isolates (n = 479) were collected from 186 cats, 143 dogs and 150 horses during 2022–2023 all over the French territory. Antibiograms were performed on all isolates. MRSA and MSSA CC398 isolates were subject to WGS. Core genome (cg) MLST-based and SNP-based phylogenetic analyses were performed using published methodologies, and characterization of the isolates was performed using publicly available tools. Results: Sixty-six MRSA isolates were identified in 14 cats (7.5%), 9 dogs (6.3%) and 43 horses (28.7%). The epidemiology of MRSA in cats and dogs remained stable since a previous study in 2015, with the presence of both CC398 and human-associated clones. In horses, in contrast, an important increase in MRSA (from 10% to 28.7%) was observed, potentially attributable to the emergence of the ST612 clones. In parallel, CC398 MSSA, a clone usually described as animal-independent, was found in 24.2% of the cat isolates. Conclusions: Our study, which is leading the way to a genomic surveillance of S. aureus in France, revealed the emergence of both MRSA ST612 in horses and MSSA CC398 in cats. These clones should be closely monitored to avoid their zoonotic spread and to understand their dynamics of transmission between humans and animals.
- 4 February 2025
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
Emergence of MRSA ST612 in horses and of MSSA CC398 in cats in France
Objectives: Staphylococcus aureus is an important zoonotic pathogen that has often been seen in animals through the prism of the MRSA clonal complex (CC) 398 in pigs and in-contact humans. The goal of this study was first to assess the prevalence of MRSA, and second to look for MSSA CC398 in cats, dogs and horses in France. Methods: Clinical S. aureus isolates (n = 479) were collected from 186 cats, 143 dogs and 150 horses during 2022–2023 all over the French territory. Antibiograms were performed on all isolates. MRSA and MSSA CC398 isolates were subject to WGS. Core genome (cg) MLST-based and SNP-based phylogenetic analyses were performed using published methodologies, and characterization of the isolates was performed using publicly available tools. Results: Sixty-six MRSA isolates were identified in 14 cats (7.5%), 9 dogs (6.3%) and 43 horses (28.7%). The epidemiology of MRSA in cats and dogs remained stable since a previous study in 2015, with the presence of both CC398 and human-associated clones. In horses, in contrast, an important increase in MRSA (from 10% to 28.7%) was observed, potentially attributable to the emergence of the ST612 clones. In parallel, CC398 MSSA, a clone usually described as animal-independent, was found in 24.2% of the cat isolates. Conclusions: Our study, which is leading the way to a genomic surveillance of S. aureus in France, revealed the emergence of both MRSA ST612 in horses and MSSA CC398 in cats. These clones should be closely monitored to avoid their zoonotic spread and to understand their dynamics of transmission between humans and animals.
- Open Access
- 20 September 2024
- Published by Springer Nature in BMC Genomics
- Vol. 25 (1) , 1-10
Unravelling the main genomic features of Mycoplasma equirhinis
Mycoplasma spp. are wall-less bacteria with small genomes (usually 0.5–1.5 Mb). Many Mycoplasma (M.) species are known to colonize the respiratory tract of both humans and livestock animals, where they act as primary pathogens or opportunists. M. equirhinis was described for the first time in 1975 in horses but has been poorly studied since, despite regular reports of around 14% prevalence in equine respiratory disorders. We recently showed that M. equirhinis is not a primary pathogen but could play a role in co-infections of the respiratory tract. This study was a set up to propose the first genomic characterization to better our understanding of the M. equirhinis species. Four circularized genomes, two of which were generated here, were compared in terms of synteny, gene content, and specific features associated with virulence or genome plasticity. An additional 20 scaffold-level genomes were used to analyse intra-species diversity through a pangenome phylogenetic approach. The M. equirhinis species showed consistent genomic homogeneity, pointing to potential clonality of isolates despite their varied geographical origins (UK, Japan and various places in France). Three different classes of mobile genetic elements have been detected: insertion sequences related to the IS1634 family, a putative prophage related to M. arthritidis and integrative conjugative elements related to M. arginini. The core genome harbours the typical putative virulence-associated genes of mycoplasmas mainly involved in cytoadherence and immune escape. M. equirhinis is a highly syntenic, homogeneous species with a limited repertoire of mobile genetic elements and putative virulence genes.
- 20 September 2024
- Published by Springer Nature in BMC Genomics
- Vol. 25 (1) , 1-10
Open AccessUnravelling the main genomic features of Mycoplasma equirhinis
Mycoplasma spp. are wall-less bacteria with small genomes (usually 0.5–1.5 Mb). Many Mycoplasma (M.) species are known to colonize the respiratory tract of both humans and livestock animals, where they act as primary pathogens or opportunists. M. equirhinis was described for the first time in 1975 in horses but has been poorly studied since, despite regular reports of around 14% prevalence in equine respiratory disorders. We recently showed that M. equirhinis is not a primary pathogen but could play a role in co-infections of the respiratory tract. This study was a set up to propose the first genomic characterization to better our understanding of the M. equirhinis species. Four circularized genomes, two of which were generated here, were compared in terms of synteny, gene content, and specific features associated with virulence or genome plasticity. An additional 20 scaffold-level genomes were used to analyse intra-species diversity through a pangenome phylogenetic approach. The M. equirhinis species showed consistent genomic homogeneity, pointing to potential clonality of isolates despite their varied geographical origins (UK, Japan and various places in France). Three different classes of mobile genetic elements have been detected: insertion sequences related to the IS1634 family, a putative prophage related to M. arthritidis and integrative conjugative elements related to M. arginini. The core genome harbours the typical putative virulence-associated genes of mycoplasmas mainly involved in cytoadherence and immune escape. M. equirhinis is a highly syntenic, homogeneous species with a limited repertoire of mobile genetic elements and putative virulence genes.
- Open Access
- 22 November 2023
- Published by Elsevier in Veterinary Microbiology
- Vol. 287, 109926
Epidemiology and pathogenicity of M. equirhinis in equine respiratory disorders
- 22 November 2023
- Published by Elsevier in Veterinary Microbiology
- Vol. 287, 109926
Open AccessEpidemiology and pathogenicity of M. equirhinis in equine respiratory disorders
- 10 November 2023
- Published by EDP Sciences in Le Nouveau Praticien Vétérinaire équine
- Vol. 17 (58) , 12-18
Bilan de la surveillance des avortements équins par le Réseau d’épidémiosurveillance en pathologie équine (RESPE)
Le Réseau d’épidémiosurveillance en pathologie équine (RESPE) surveille les avortements équins présumés infectieux depuis 2009 pour détecter précocement un cas ou un foyer, afin de rapidement mettre en place des mesures de gestion et limiter l’impact sur la santé animale et sur l’économie de la filière équine française. Quatre maladies contagieuses abortives d’intérêt collectif sont surveillées : l’artérite virale équine, les infections par l’herpèsvirus équin 1 ou 4 et la leptospirose. Entre 2009 et 2022, 522 vétérinaires sentinelles ont déclaré 2 411 avortements survenus dans des structures équestres majoritairement d’élevage, ayant un effectif moyen de 51 équidés. Les races Pur-Sang, Trotteur Français et Selle Français étaient majoritairement représentées. Ces avortements sont survenus en moyenne au cours du 8e mois de gestation. La présence d’un organisme pathogène abortif a été mise en évidence dans seulement 6,0 % des prélèvements analysés; l’herpèsvirus 1 a été majoritairement détecté. Les trois quarts des avortements ont été déclarés dans les deux jours suivant leur détection par le détenteur de la jument. Cette réactivité est satisfaisante pour détecter précocement un foyer d’avortement infectieux et mettre rapidement en place des mesures de gestion, le cas échéant. Le RESPE est associé à un projet de recherche visant à évaluer l’apport des méthodes de séquençage haut débit dans l’amélioration de la surveillance des infections abortives des équidés en France.
- 10 November 2023
- Published by EDP Sciences in Le Nouveau Praticien Vétérinaire équine
- Vol. 17 (58) , 12-18
Bilan de la surveillance des avortements équins par le Réseau d’épidémiosurveillance en pathologie équine (RESPE)
Le Réseau d’épidémiosurveillance en pathologie équine (RESPE) surveille les avortements équins présumés infectieux depuis 2009 pour détecter précocement un cas ou un foyer, afin de rapidement mettre en place des mesures de gestion et limiter l’impact sur la santé animale et sur l’économie de la filière équine française. Quatre maladies contagieuses abortives d’intérêt collectif sont surveillées : l’artérite virale équine, les infections par l’herpèsvirus équin 1 ou 4 et la leptospirose. Entre 2009 et 2022, 522 vétérinaires sentinelles ont déclaré 2 411 avortements survenus dans des structures équestres majoritairement d’élevage, ayant un effectif moyen de 51 équidés. Les races Pur-Sang, Trotteur Français et Selle Français étaient majoritairement représentées. Ces avortements sont survenus en moyenne au cours du 8e mois de gestation. La présence d’un organisme pathogène abortif a été mise en évidence dans seulement 6,0 % des prélèvements analysés; l’herpèsvirus 1 a été majoritairement détecté. Les trois quarts des avortements ont été déclarés dans les deux jours suivant leur détection par le détenteur de la jument. Cette réactivité est satisfaisante pour détecter précocement un foyer d’avortement infectieux et mettre rapidement en place des mesures de gestion, le cas échéant. Le RESPE est associé à un projet de recherche visant à évaluer l’apport des méthodes de séquençage haut débit dans l’amélioration de la surveillance des infections abortives des équidés en France.
- Open Access
- 12 July 2023
- Published by Wiley in Reproduction in Domestic Animals
- Vol. 58 (S2) , 93-101
Overview of the causes of abortion in horses, their follow‐up and management
Abortions in horses represent an important health and economic challenge for equine industry. Primary causes of abortion are divided in non‐infectious and infectious. Non‐infectious causes include abnormalities of foetal appendices (umbilical cord and placenta essentially), abnormalities of gestation, maternal and foetal origins. Infectious abortions are caused in almost cases by bacterial infections, followed by viruses, fungi and parasites. New abortive pathogens (asLeptospira, Neospora caninum, Coxiella burnetii,Chlamydophila abortus, and) have been confirmed in equines by comparison already known for their abortive properties in human or in other species. Despite an increasing number of autopsies and continuous improvements in diagnostic tools, in management and surveillance, 20%–40% of the causes of equine abortion remain unknown depending on the country. To increase the likelihood of a definitive diagnosis in cases of abortion and stillbirth in horses, new diagnostic approaches are needed.
- 12 July 2023
- Published by Wiley in Reproduction in Domestic Animals
- Vol. 58 (S2) , 93-101
Open AccessOverview of the causes of abortion in horses, their follow‐up and management
Abortions in horses represent an important health and economic challenge for equine industry. Primary causes of abortion are divided in non‐infectious and infectious. Non‐infectious causes include abnormalities of foetal appendices (umbilical cord and placenta essentially), abnormalities of gestation, maternal and foetal origins. Infectious abortions are caused in almost cases by bacterial infections, followed by viruses, fungi and parasites. New abortive pathogens (asLeptospira, Neospora caninum, Coxiella burnetii,Chlamydophila abortus, and) have been confirmed in equines by comparison already known for their abortive properties in human or in other species. Despite an increasing number of autopsies and continuous improvements in diagnostic tools, in management and surveillance, 20%–40% of the causes of equine abortion remain unknown depending on the country. To increase the likelihood of a definitive diagnosis in cases of abortion and stillbirth in horses, new diagnostic approaches are needed.
- Open Access
- 9 January 2023
- Published by Wiley in Equine Veterinary Journal
- Vol. 55 (5) , 747-754
Detection of Mycoplasma spp. in horses with respiratory disorders
Background: Bacteria belonging to the genus Mycoplasma are small‐sized, have no cell walls and small genomes. They commonly cause respiratory disorders in their animal hosts. Three species have been found in the respiratory tract of horses worldwide, that is., Mycoplasma ( M. ) equirhinis , M. pulmonis and M. felis , but their role in clinical cases remains unclear. Objectives: The aim of this study was to i) develop and validate tools to detect, isolate and identify different Mycoplasma spp. strains in clinical equine respiratory‐tract specimens and ii) subsequently define the prevalence of the three species in France depending on sample types and horse characteristics (age, breed, sex). Study design: Validation of a workflow for mycoplasma diagnosis and subsequent prevalence study. Methods: Mycoplasma‐free tracheal wash samples spiked with numerated strains and DNA dilutions were used to validate the culture methods and real‐time PCR (rt‐PCR) assay. Isolated strains were identified by 16S rRNA gene sequencing. Prevalences were determined on a population of 616 horses with respiratory disorders, sampled in France in 2020. Results: In total, 104 horses (16.9%) were found to be positive for Mycoplasma spp. by at least one method. M. equirhinis was the predominant circulating species, accounting for 85% of the rt‐PCR‐positive samples and 98% of the 40 cultured strains. Main limitation: The proposed pre‐enrichment procedure improves the sensitivity of detection but hinders the quantification of the initial mycoplasma load in the clinical specimens. Conclusions: Prevalence of mycoplasma varied with age, breed, and type of sample.
- 9 January 2023
- Published by Wiley in Equine Veterinary Journal
- Vol. 55 (5) , 747-754
Open AccessDetection of Mycoplasma spp. in horses with respiratory disorders
Background: Bacteria belonging to the genus Mycoplasma are small‐sized, have no cell walls and small genomes. They commonly cause respiratory disorders in their animal hosts. Three species have been found in the respiratory tract of horses worldwide, that is., Mycoplasma ( M. ) equirhinis , M. pulmonis and M. felis , but their role in clinical cases remains unclear. Objectives: The aim of this study was to i) develop and validate tools to detect, isolate and identify different Mycoplasma spp. strains in clinical equine respiratory‐tract specimens and ii) subsequently define the prevalence of the three species in France depending on sample types and horse characteristics (age, breed, sex). Study design: Validation of a workflow for mycoplasma diagnosis and subsequent prevalence study. Methods: Mycoplasma‐free tracheal wash samples spiked with numerated strains and DNA dilutions were used to validate the culture methods and real‐time PCR (rt‐PCR) assay. Isolated strains were identified by 16S rRNA gene sequencing. Prevalences were determined on a population of 616 horses with respiratory disorders, sampled in France in 2020. Results: In total, 104 horses (16.9%) were found to be positive for Mycoplasma spp. by at least one method. M. equirhinis was the predominant circulating species, accounting for 85% of the rt‐PCR‐positive samples and 98% of the 40 cultured strains. Main limitation: The proposed pre‐enrichment procedure improves the sensitivity of detection but hinders the quantification of the initial mycoplasma load in the clinical specimens. Conclusions: Prevalence of mycoplasma varied with age, breed, and type of sample.
- 1 January 2023
- Published by EDP Sciences in Le Nouveau Praticien Vétérinaire équine
- Vol. 17-18 (61-62) , 94-100
Caractérisation in vitro de l’effet antimicrobien des huiles essentielles utilisées comme thérapie alternative en médecine vétérinaire équine
Pour la première fois, une caractérisation chimique des huiles essentielles (HE) a été réalisée en parallèle de la caractérisation de leur spectre d’activité in vitro. Elle entrevoit une sortie de l’impasse thérapeutique causée par l’augmentation de la résistance aux antibiotiques. De plus, cette étude révèle l’intérêt des huiles essentielles dont l’effet antibactérien est observé indifféremment sur une souche de phénotype sauvage et de phénotype résistant isolée d’un cas clinique. Elle avertit également sur la cytotoxicité in vitro des huiles essentielles, qui n’a pas permis de vérifier l’effet antiviral avec le modèle cellulaire utilisé en laboratoire. Par ailleurs, cette étude a permis de comparer l’effet des huiles essentielles par rapport à leur principe actif, mettant en évidence des synergies ou des antagonismes selon les molécules actives au sein d’une même huile. Elle contribue à fournir à la communauté scientifique des éléments chiffrés à prendre en compte comme base pour l’utilisation in vivo des huiles essentielles comme thérapie complémentaire chez le cheval.
- 1 January 2023
- Published by EDP Sciences in Le Nouveau Praticien Vétérinaire équine
- Vol. 17-18 (61-62) , 94-100
Caractérisation in vitro de l’effet antimicrobien des huiles essentielles utilisées comme thérapie alternative en médecine vétérinaire équine
Pour la première fois, une caractérisation chimique des huiles essentielles (HE) a été réalisée en parallèle de la caractérisation de leur spectre d’activité in vitro. Elle entrevoit une sortie de l’impasse thérapeutique causée par l’augmentation de la résistance aux antibiotiques. De plus, cette étude révèle l’intérêt des huiles essentielles dont l’effet antibactérien est observé indifféremment sur une souche de phénotype sauvage et de phénotype résistant isolée d’un cas clinique. Elle avertit également sur la cytotoxicité in vitro des huiles essentielles, qui n’a pas permis de vérifier l’effet antiviral avec le modèle cellulaire utilisé en laboratoire. Par ailleurs, cette étude a permis de comparer l’effet des huiles essentielles par rapport à leur principe actif, mettant en évidence des synergies ou des antagonismes selon les molécules actives au sein d’une même huile. Elle contribue à fournir à la communauté scientifique des éléments chiffrés à prendre en compte comme base pour l’utilisation in vivo des huiles essentielles comme thérapie complémentaire chez le cheval.
- Open Access
Antimicrobial Resistance and Genetic Diversity of Pseudomonas aeruginosa Strains Isolated from Equine and Other Veterinary Samples
Pseudomonas aeruginosa is one of the leading causes of healthcare-associated infections in humans. This bacterium is less represented in veterinary medicine, despite causing difficult-to-treat infections due to its capacity to acquire antimicrobial resistance, produce biofilms, and persist in the environment, along with its limited number of veterinary antibiotic therapies. Here, we explored susceptibility profiles to antibiotics and to didecyldimethylammonium chloride (DDAC), a quaternary ammonium widely used as a disinfectant, in 168 P. aeruginosa strains isolated from animals, mainly Equidae. A genomic study was performed on 41 of these strains to determine their serotype, sequence type (ST), relatedness, and resistome. Overall, 7.7% of animal strains were resistant to carbapenems, 10.1% presented a multidrug-resistant (MDR) profile, and 11.3% showed decreased susceptibility (DS) to DDAC. Genomic analyses revealed that the study population was diverse, and 4.9% were ST235, which is considered the most relevant human high-risk clone worldwide. This study found P. aeruginosa populations with carbapenem resistance, multidrug resistance, and DS to DDAC in equine and canine isolates. These strains, which are not susceptible to antibiotics used in veterinary and human medicine, warrant close the setting up of a clone monitoring, based on that already in place in human medicine, in a one-health approach.
Open AccessAntimicrobial Resistance and Genetic Diversity of Pseudomonas aeruginosa Strains Isolated from Equine and Other Veterinary Samples
Pseudomonas aeruginosa is one of the leading causes of healthcare-associated infections in humans. This bacterium is less represented in veterinary medicine, despite causing difficult-to-treat infections due to its capacity to acquire antimicrobial resistance, produce biofilms, and persist in the environment, along with its limited number of veterinary antibiotic therapies. Here, we explored susceptibility profiles to antibiotics and to didecyldimethylammonium chloride (DDAC), a quaternary ammonium widely used as a disinfectant, in 168 P. aeruginosa strains isolated from animals, mainly Equidae. A genomic study was performed on 41 of these strains to determine their serotype, sequence type (ST), relatedness, and resistome. Overall, 7.7% of animal strains were resistant to carbapenems, 10.1% presented a multidrug-resistant (MDR) profile, and 11.3% showed decreased susceptibility (DS) to DDAC. Genomic analyses revealed that the study population was diverse, and 4.9% were ST235, which is considered the most relevant human high-risk clone worldwide. This study found P. aeruginosa populations with carbapenem resistance, multidrug resistance, and DS to DDAC in equine and canine isolates. These strains, which are not susceptible to antibiotics used in veterinary and human medicine, warrant close the setting up of a clone monitoring, based on that already in place in human medicine, in a one-health approach.
- Open Access
- 1 March 2021
- Published by Microbiology Society in Microbial Genomics
- Vol. 7 (3) , 000528
Globetrotting strangles: the unbridled national and international transmission of Streptococcus equi between horses
The equine disease strangles, which is characterized by the formation of abscesses in the lymph nodes of the head and neck, is one of the most frequently diagnosed infectious diseases of horses around the world. The causal agent, Streptococcus equi subspecies equi , establishes a persistent infection in approximately 10 % of animals that recover from the acute disease. Such ‘carrier’ animals appear healthy and are rarely identified during routine veterinary examinations pre-purchase or transit, but can transmit S. equi to naïve animals initiating new episodes of disease. Here, we report the analysis and visualization of phylogenomic and epidemiological data for 670 isolates of S. equi recovered from 19 different countries using a new core-genome multilocus sequence typing (cgMLST) web bioresource. Genetic relationships among all 670 S. equi isolates were determined at high resolution, revealing national and international transmission events that drive this endemic disease in horse populations throughout the world. Our data argue for the recognition of the international importance of strangles by the Office International des Épizooties to highlight the health, welfare and economic cost of this disease. The Pathogenwatch cgMLST web bioresource described herein is available for tailored genomic analysis of populations of S. equi and its close relative S. equi subspecies zooepidemicus that are recovered from horses and other animals, including humans, throughout the world. This article contains data hosted by Microreact.
- 1 March 2021
- Published by Microbiology Society in Microbial Genomics
- Vol. 7 (3) , 000528
Open AccessGlobetrotting strangles: the unbridled national and international transmission of Streptococcus equi between horses
The equine disease strangles, which is characterized by the formation of abscesses in the lymph nodes of the head and neck, is one of the most frequently diagnosed infectious diseases of horses around the world. The causal agent, Streptococcus equi subspecies equi , establishes a persistent infection in approximately 10 % of animals that recover from the acute disease. Such ‘carrier’ animals appear healthy and are rarely identified during routine veterinary examinations pre-purchase or transit, but can transmit S. equi to naïve animals initiating new episodes of disease. Here, we report the analysis and visualization of phylogenomic and epidemiological data for 670 isolates of S. equi recovered from 19 different countries using a new core-genome multilocus sequence typing (cgMLST) web bioresource. Genetic relationships among all 670 S. equi isolates were determined at high resolution, revealing national and international transmission events that drive this endemic disease in horse populations throughout the world. Our data argue for the recognition of the international importance of strangles by the Office International des Épizooties to highlight the health, welfare and economic cost of this disease. The Pathogenwatch cgMLST web bioresource described herein is available for tailored genomic analysis of populations of S. equi and its close relative S. equi subspecies zooepidemicus that are recovered from horses and other animals, including humans, throughout the world. This article contains data hosted by Microreact.